Elite in CACH Syndrome

Dr. Amit Bar

Neurology
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
On Staff At
Accepting New Patients
Elite in CACH Syndrome
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amit Bar is a Neurologist in Philadelphia, Pennsylvania. Dr. Bar is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Encephalitis. Dr. Bar is currently accepting new patients.

His clinical research consists of co-authoring 397 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 43 articles and participated in 4 clinical trials in the study of CACH Syndrome.

Graduate Institution
McGill University
Residency
Massachusetts General Hospital
Specialties
Neurology
Licenses
Psychiatry & Neurology in PA
Board Certifications
Neurology, 1998
Fellowships
Massachusetts General Hospital/Brigham and Women’s Hospital
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 10 Less Insurance Carriers -

Locations

Penn Neuroscience Center - Neurology
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
Enrollment Status: Terminated
Publish Date: August 22, 2025
Intervention Type: Drug, Biological
Study Drugs: Moderna mRNA-1273, BNT162b2, Ad26.COV2.S, IS (MMF or MPA), IS (MTX), IS (B cell Depletion Therapy)
Study Phase: Phase 2
Analysis of Lymphatic Fluid From the Thoracic Duct of Healthy People and People With Multiple Sclerosis (MS) Before and After Ofatumumab Treatment
Analysis of Lymphatic Fluid From the Thoracic Duct of Healthy People and People With Multiple Sclerosis (MS) Before and After Ofatumumab Treatment
Enrollment Status: Enrolling_by_invitation
Publish Date: August 19, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
A Phase 1/2, Two-part, Open-label Dose-escalation and Double-blind, Placebo-controlled Dose-expansion Study With an Open-label Extension to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
Enrollment Status: Terminated
Publish Date: February 23, 2024
Intervention Type: Drug, Biological
Study Drug: ATA188
Study Phase: Phase 1/Phase 2
An Investigator-initiated, Multicenter, Phase IV, Open-label Study to Evaluate the Biological Basis for Disease Progression in Relapsing-remitting Multiple Sclerosis Patients Treated in Routine Practice With Gilenya for 2 Years
An Investigator-initiated, Multicenter, Phase IV, Open-label Study to Evaluate the Biological Basis for Disease Progression in Relapsing-remitting Multiple Sclerosis Patients Treated in Routine Practice With Gilenya for 2 Years
Enrollment Status: Completed
Publish Date: November 09, 2018
Intervention Type: Drug
View 3 Less Clinical Trials

397 Total Publications

Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic.
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic.
Journal: Neurology
Published: September 02, 2025
Similar Doctors
Elite in CACH Syndrome
Dr. Adeline L. Vanderver
Pediatric Neurology | Neurology
Elite in CACH Syndrome
Dr. Adeline L. Vanderver
Pediatric Neurology | Neurology

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1000
Languages Spoken:
English
See accepted insurances

Adeline Vanderver is a Pediatric Neurologist and a Neurologist in Philadelphia, Pennsylvania. Dr. Vanderver is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are Aicardi-Goutieres Syndrome, Leukodystrophy, CACH Syndrome, Pol 3-Related Leukodystrophy, and Gastrostomy.

Elite in CACH Syndrome
Dr. Amy T. Waldman
Pediatric Neurology | Pediatrics | Neurology
Elite in CACH Syndrome
Dr. Amy T. Waldman
Pediatric Neurology | Pediatrics | Neurology

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1000
Languages Spoken:
English
See accepted insurances

Amy Waldman is a Pediatric Neurologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Waldman is rated as a Distinguished provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are CACH Syndrome, Multiple Sclerosis (MS), Leukodystrophy, Optic Neuritis, and Gastrostomy.

Distinguished in CACH Syndrome
Dr. Brenda L. Banwell
Pediatrics | Pediatric Neurology | Neurology
Distinguished in CACH Syndrome
Dr. Brenda L. Banwell
Pediatrics | Pediatric Neurology | Neurology
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Neurology, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1719
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brenda Banwell is a Pediatrics specialist and a Pediatric Neurologist in Philadelphia, Pennsylvania. Dr. Banwell is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bar's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile